The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends on ...

DuckDuckGo lets you turn off AI searches and prioritizes your privacy. Google packs class-leading features. Which one should you choose? We help you decide. I've been testing PC and mobile software ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an unusually ambitious goal: building AI systems capable of improving themselves ...

From selling hood DVDs to the VERZUZ stage, French Montana has one hell of a career. Here are his 20 best songs.

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

According to @_avichawla on Twitter, MIT researchers detail Recursive LLMs that call themselves to decompose tasks, verify intermediate steps, and iterate until convergence; as reported by MIT CSAIL ...

Ticket prices to the 2026 World Cup hit an all-time high on Wednesday, when FIFA rolled out its fourth and final phase of sales for the summer showcase. With soccer’s governing body continuing to ...

Elon Musk, famously a man with big ideas, is building a semiconductor plant vast enough to power those ambitions. Musk on Saturday announced what he calls the "Terafab," a semiconductor manufacturing ...